by synergycap1 | Aug 10, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
Adjusted EPS: Loss of 16 cents per share vs. loss of 14 cents per share expected by a Thomson Reuters consensus estimate Revenue: $181.7 million vs. $186.2 million expected by a Thomson Reuters consensus estimate Daily active users (DAUs): 173 million vs. 175.2...
by synergycap1 | Aug 10, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
(Reuters) – Venture capital firm Benchmark Capital is suing former Uber Chief Executive Officer Travis Kalanick to force him to leave the board of the ride services company and rescind his ability to fill three board seats, according to a copy of the lawsuit...
by synergycap1 | Aug 10, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
(Reuters) – Nordstrom Inc (JWN.N) reported better-than-expected quarterly same-store sales on Thursday as more people shopped at the apparel retailer’s online stores, sending shares up 2.5 percent after the bell. Nordstrom said net income fell to $110...
by synergycap1 | Aug 10, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Working Capital
Executive Summary One of the mistakes CEOs often make with their diversity efforts is assuming everyone shares their goals. In fact, that’s usually not the case. For recent evidence of this, look to Google’s firing of James Damore. This software engineer...
by synergycap1 | Aug 10, 2017 | Bad Credit Loans, Bank Lending, Business Loans, Finance, Working Capital
Watching markets function would not make for a good spectator sport on TV, but the process does have its charms and we recommend it highly — especially when freight transportation is involved. Two of our stories, one on CSX service delays and another on the...
by synergycap1 | Aug 10, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
An imbalance in supply and demand is the root cause of recent pain for companies like Mylan and Teva Pharmaceuticals, said Chip Davis, CEO of the Association for Accessible Medicines, the trade group for generic and biosimilar medicines. “[Analysts are] pointing...
